The global Immunohistochemistry Market is valued at an estimated USD 3.4 billion in 2024 and is projected to reach USD 5.2 ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

The Pakistan Federal Union of Journalists (PFUJ) has filed a petition in the Islamabad High Court challenging the recent amendments to the country's cybercrime law, calling for them to be struck ...

The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer ...

During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast ...

The feasibility of this classification was validated in a separate validation cohort (n=241) using immunohistochemistry (IHC) from the Retroperitoneal SArcoma Registry (RESAR). The study is registered ...

Concordance between human epidermal growth factor receptor 2 (HER2) status by immunohistochemistry (IHC) and next-generation sequencing (NGS) in tissue and blood samples from gastric and ...

The expression of select URGs was validated using qRT-PCR and immunohistochemistry (IHC). Results: We identified WDR74 and TNFRSF12A as pivotal ubiquitination-related genes associated with OA, ...

ISLAMABAD: The Islam­abad High Court (IHC) was informed on Friday that the US government has declined to approve a clemency petition for the release of Dr Aafia Siddiqui, a Pakistani ...